Aflac fourth quarter revenues boost 6.

Consequently, if the yen/dollar exchange rate averages 90 yen for the full 12 months, it's likely operating earnings per diluted share can be $6.37 to $6.57 for 2013. I would explain that 2013 revenue comparisons to 2012 could be more difficult because earnings in 2012 were significantly much better than we originally anticipated.’.. Aflac fourth quarter revenues boost 6.6 percent to $6.4 billion Aflac Incorporated today reported its fourth quarter outcomes. Reflecting the weaker yen/dollar exchange rate, revenues rose 6.6 percent to $6.4 billion in the fourth quarter of 2012, weighed against $6.0 billion in the fourth quarter of 2011.Gupta, who also serves as a particular government worker of the FDA Analgesic and Anesthetic Drug Products Advisory Committee, expressed ASA’s support for expanding access to naloxone to more non-medical staff. Dr. Gupta described that the federal government and stakeholders should raise the availability of naloxone to people more likely to witness an opioid overdose and teach them on how to recognize an opioid overdose, and on effective resuscitation and post-resuscitation care.